Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.
Description
Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.
API Access
Has API
No
API Access
Has API
No
Integrations
Evo Designer
Yes
GitHub
Yes
Hugging Face
Yes
NVIDIA BioNeMo
Yes
Integrations
Evo Designer
No
GitHub
No
Hugging Face
No
NVIDIA BioNeMo
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Arc Institute
Country
United States
Website
arcinstitute.org/tools/evo
Vendor Details
Company Name
Reliant AI
Website
www.reliant.ai/
Product Features
Product Features
Artificial Intelligence
Chatbot
No
For Healthcare
No
For Sales
No
For eCommerce
No
Image Recognition
No
Machine Learning
No
Multi-Language
No
Natural Language Processing
No
Predictive Analytics
No
Process/Workflow Automation
No
Rules-Based Automation
No
Virtual Personal Assistant (VPA)
No